• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过与七(2,6-二-O-甲基)-β-环糊精形成包合物改善氟比洛芬的溶出度和栓剂释放特性。

Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.

作者信息

Uekama K, Imai T, Maeda T, Irie T, Hirayama F, Otagiri M

出版信息

J Pharm Sci. 1985 Aug;74(8):841-5. doi: 10.1002/jps.2600740808.

DOI:10.1002/jps.2600740808
PMID:4032267
Abstract

The inclusion behavior of methylated beta-cyclodextrins, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and heptakis-(2,3,6-tri-O-methyl)-beta-cyclodextrin in solution and the solid state was compared with that of natural beta-cyclodextrin using an anti-inflammatory drug, flurbiprofen, as a guest molecule. Stability constants were determined by the solubility method at various temperatures, and the thermodynamic parameters were calculated for inclusion complex formation in aqueous solution. The solid complexes were obtained in a molar ratio of 1:1, and their dissolution behavior and release from suppository bases were examined. The data suggest that the inclusion mode of the complex with 3 is somewhat different from that of the complexes with 1 and 2. From a practical point of view, 2 seems to be particularly useful for improving the pharmaceutical properties of flurbiprofen in various dosage forms.

摘要

以抗炎药物氟比洛芬作为客体分子,将甲基化β-环糊精、七(2,6-二-O-甲基)-β-环糊精和七(2,3,6-三-O-甲基)-β-环糊精在溶液和固态中的包合行为与天然β-环糊精的包合行为进行了比较。通过溶解度法在不同温度下测定了稳定常数,并计算了在水溶液中形成包合物的热力学参数。以1:1的摩尔比获得了固体配合物,并研究了它们的溶解行为和从栓剂基质中的释放情况。数据表明,与3形成的配合物的包合模式与与1和2形成的配合物的包合模式略有不同。从实际角度来看,2似乎对改善氟比洛芬在各种剂型中的药物性质特别有用。

相似文献

1
Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.通过与七(2,6-二-O-甲基)-β-环糊精形成包合物改善氟比洛芬的溶出度和栓剂释放特性。
J Pharm Sci. 1985 Aug;74(8):841-5. doi: 10.1002/jps.2600740808.
2
Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.七(2,6-二-O-甲基)-β-环糊精与抗肿瘤药物苯丁酸氮芥的络合作用
J Pharm Sci. 1989 May;78(5):427-31. doi: 10.1002/jps.2600780517.
3
Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
J Pharmacobiodyn. 1982 Dec;5(12):1027-9. doi: 10.1248/bpb1978.5.1027.
4
Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.氯巴占与环糊精在溶液和固态下的相互作用研究。
Chem Pharm Bull (Tokyo). 1990 Mar;38(3):728-32. doi: 10.1248/cpb.38.728.
5
Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.β-环糊精与三-O-甲基-β-环糊精在水溶液中与几种药物包合作用的比较研究。
Acta Pharm Suec. 1984;21(6):357-66.
6
Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
Pharmazie. 1984 Oct;39(10):697-9.
7
Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.环糊精包合物之间的定量结构-稳定性关系。I:巴比妥酸衍生物。
J Pharm Sci. 1985 Feb;74(2):211-3. doi: 10.1002/jps.2600740223.
8
Inclusion mode of flurbiprofen with beta-cyclodextrin and heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin, and improvements of some pharmaceutical properties of flurbiprofen by complexation.
Chem Pharm Bull (Tokyo). 1988 Jan;36(1):354-9. doi: 10.1248/cpb.36.354.
9
Improvement of dissolution characteristics of psoralen by cyclodextrins complexation.
Farmaco. 1995 Jul-Aug;50(7-8):543-7.
10
Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.麦芽糊精-β-环糊精、七(2,6-二-O-甲基)-β-环糊精和β-环糊精与岩藻甾醇在水相和固态下包合络合的比较研究。
J Pharm Pharmacol. 1993 Dec;45(12):1028-32. doi: 10.1111/j.2042-7158.1993.tb07174.x.

引用本文的文献

1
Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.吡罗昔康-β-环糊精、吡罗昔康和吲哚美辛对人体胃电位差和黏膜损伤的安慰剂对照比较。
Dig Dis Sci. 1992 Dec;37(12):1825-32. doi: 10.1007/BF01308075.